CD274 and neoplasm: Factors in the tumor microenvironment (TME) such as programmed death-ligand 1 (PD-L1) positivity and tumor-infiltrating lymphocytes (TIL) can serve as biomarkers to predict the efficacy of ICIs in HNSCC [7, 8].